Sarah Ashmore, Abigail Steinbeck, Nicholas Scioscia, Ashlee Weaver, Jessica C Sassani
{"title":"Concomitant Overactive Bladder Treatment and Adherence to Pelvic Floor Physical Therapy.","authors":"Sarah Ashmore, Abigail Steinbeck, Nicholas Scioscia, Ashlee Weaver, Jessica C Sassani","doi":"10.1007/s00192-025-06209-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and hypothesis: </strong>There is limited literature regarding concomitant initiation of pelvic floor physical therapy (PFPT) and medications for overactive bladder treatment. PFPT improves patient symptoms, although adherence tends to be low. This retrospective cohort study assessed PFPT adherence of female patients with overactive bladder at a tertiary care center who were referred to PFPT. We hypothesized that concomitant PFPT and medication would correlate with decreased PFPT adherence among patients with overactive bladder.</p><p><strong>Methods: </strong>Adherence to PFPT (defined as ≥ 50% attendance of the recommended sessions) was compared in patients with (PT + Med group) and in those without (PT group) concomitant medication prescription.</p><p><strong>Results: </strong>We evaluated 346 patients, with 196 in the PT group and 150 in the PT + Med group. The PT + Med group had a higher body mass index (30.0 kg/m<sup>2</sup> vs 27.5 kg/m<sup>2</sup>, p < 0.001), a higher rate of diabetes (20.7% vs 11.7%, p = 0.02), and higher urogenital distress inventory scores at baseline (p < 0.001). The PT group completed more PT sessions (p < 0.001) and was more likely to be adherent (30.6% vs 15.3%, p < 0.001). The PT + Med group was more likely to progress to minimally invasive therapy (10.0% vs 4.1%, p = 0.03). On multivariable logistic regression model, PFPT adherence remained significantly lower for the PT + Med group when controlling for comorbidities (adjusted OR 0.38, p = 0.001).</p><p><strong>Conclusions: </strong>The addition of medication at the time of PFPT referral was associated with decreased PFPT adherence in overactive bladder patients.</p>","PeriodicalId":14355,"journal":{"name":"International Urogynecology Journal","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urogynecology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00192-025-06209-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and hypothesis: There is limited literature regarding concomitant initiation of pelvic floor physical therapy (PFPT) and medications for overactive bladder treatment. PFPT improves patient symptoms, although adherence tends to be low. This retrospective cohort study assessed PFPT adherence of female patients with overactive bladder at a tertiary care center who were referred to PFPT. We hypothesized that concomitant PFPT and medication would correlate with decreased PFPT adherence among patients with overactive bladder.
Methods: Adherence to PFPT (defined as ≥ 50% attendance of the recommended sessions) was compared in patients with (PT + Med group) and in those without (PT group) concomitant medication prescription.
Results: We evaluated 346 patients, with 196 in the PT group and 150 in the PT + Med group. The PT + Med group had a higher body mass index (30.0 kg/m2 vs 27.5 kg/m2, p < 0.001), a higher rate of diabetes (20.7% vs 11.7%, p = 0.02), and higher urogenital distress inventory scores at baseline (p < 0.001). The PT group completed more PT sessions (p < 0.001) and was more likely to be adherent (30.6% vs 15.3%, p < 0.001). The PT + Med group was more likely to progress to minimally invasive therapy (10.0% vs 4.1%, p = 0.03). On multivariable logistic regression model, PFPT adherence remained significantly lower for the PT + Med group when controlling for comorbidities (adjusted OR 0.38, p = 0.001).
Conclusions: The addition of medication at the time of PFPT referral was associated with decreased PFPT adherence in overactive bladder patients.
介绍和假设：关于骨盆底物理治疗（PFPT）和药物治疗膀胱过度活动的同时开始的文献有限。PFPT可改善患者症状，但依从性往往较低。本回顾性队列研究评估了在三级保健中心接受PFPT治疗的女性膀胱过度活动患者的PFPT依从性。我们假设伴随PFPT和药物治疗与膀胱过度活动患者PFPT依从性降低相关。方法：比较有（PT + Med组）和没有（PT组）联合用药的患者对PFPT的依从性（定义为≥50%的推荐疗程的出勤率）。结果：我们评估了346例患者，其中PT组196例，PT + Med组150例。PT + Med组的体重指数更高（30.0 kg/m2 vs 27.5 kg/m2, p < 0.001），糖尿病发生率更高（20.7% vs 11.7%, p = 0.02），基线时泌尿生殖窘迫量表得分更高（p < 0.001）。PT组完成了更多的PT疗程（p < 0.001），并且更有可能坚持治疗（30.6% vs 15.3%, p < 0.001）。PT + Med组更有可能进展到微创治疗（10.0% vs 4.1%, p = 0.03）。在多变量logistic回归模型中，在控制合并症的情况下，PT + Med组的PFPT依从性仍显著降低（校正OR 0.38, p = 0.001）。结论：在膀胱过度活动患者转介PFPT时添加药物与PFPT依从性降低有关。
期刊介绍：
The International Urogynecology Journal is the official journal of the International Urogynecological Association (IUGA).The International Urogynecology Journal has evolved in response to a perceived need amongst the clinicians, scientists, and researchers active in the field of urogynecology and pelvic floor disorders. Gynecologists, urologists, physiotherapists, nurses and basic scientists require regular means of communication within this field of pelvic floor dysfunction to express new ideas and research, and to review clinical practice in the diagnosis and treatment of women with disorders of the pelvic floor. This Journal has adopted the peer review process for all original contributions and will maintain high standards with regard to the research published therein. The clinical approach to urogynecology and pelvic floor disorders will be emphasized with each issue containing clinically relevant material that will be immediately applicable for clinical medicine. This publication covers all aspects of the field in an interdisciplinary fashion
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
